Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,778.40
(
-0.07%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
110.40
(
3.58%
)
Bitcoin
70,439.30
(
-1.13%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 70568

Friday, 12/18/2009 6:15:14 PM

Friday, December 18, 2009 6:15:14 PM

Post# of 257257
MNTA:

I can take a guess that product 4 [M178] is Neulasta and it's also for $10M in milestones. Leaving $168M for C+L.

We may never know what the drug was, but you were pretty close on the numbers: $163M of potential milestones remain for Copaxone and Lovenox.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today